Serum IgG levels demonstrate seasonal change in connective tissue diseases: A large-scale, 4-year analysis in Japanese

Modern Rheumatology

Volumn 22, Issue 3, 2012, Pages 426-430

  Terao, Chikashi ^a   Ohmura, Koichiro ^a   Yamamoto, Keiichi ^b   Yukawa, Naoichiro ^a   Kawabata, Daisuke ^a   Nojima, Takaki ^a   Fujii, Takao ^a   Mimori, Tsuneyo ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Connective tissue disease; Immunoglobulin; Rheumatoid arthritis; Serologic marker; Systemic lupus erythematosus

Indexed keywords

DNA ANTIBODY; IMMUNOGLOBULIN G;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ACTIVITY; FEMALE; HUMAN; HYPERGAMMAGLOBULINEMIA; JAPANESE; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; POLYMYOSITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEASONAL VARIATION; SUMMER; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; WINTER;

ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; IMMUNOGLOBULIN G; JAPAN; MALE; MIDDLE AGED; SEASONS;

EID: 84865392564     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-011-0535-3     Document Type: Article

References (18)

1. Ehrenstein MR, Isenberg DA. Hypergammaglobulinaemia and autoimmune rheumatic diseases. Ann Rheum Dis. 1992;51(11): 1185-7.
2. Hahn BH. Antibodies to DNA. N Engl J Med. 1998;338(19): 1359-68. (Pubitemid 28216666)
3. Schur PH, Sandson J. Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med. 1968;278(10): 533-8.
4. ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CG. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study. Arthritis Rheum. 1990;33(5):634-43. (Pubitemid 20166564)
5. Saito T, Fukuda H, Arisue M, Matsuda A, Shindoh M, Amemiya A, et al. Periductal lymphocytic infiltration of salivary glands in Sjogren's syndrome with relation to clinical and immunologic findings. Oral Surg Oral Med Oral Pathol. 1991;71(2):179-83.
6. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315-24. (Pubitemid 18091653)
7. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.
8. Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: Addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum. 2001;44(3):735-6. (Pubitemid 32234635)
9. Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sjogren's syndrome (1999): Availability and validity. Mod Rheumatol. 2004;14(6):425-34. (Pubitemid 40028665)
10. Doria A, Ghirardello A, de Zambiasi P, Ruffatti A, Gambari PF. Japanese diagnostic criteria for mixed connective tissue disease in Caucasian patients. J Rheumatol. 1992;19(2):259-64.
11. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344-7.
12. Komai K, Shiozawa K, Tanaka Y, Yoshihara R, Tanaka C, Sakai H, et al. Sjogren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment. Mod Rheumatol. 2009;19(4):416-9.
13. Miyamae T, Ito S, Machida H, Ozawa R, Higuchi R, Nakajima S, et al. Clinical features and laboratory findings in children with both anti-dsDNA and anti-U1-RNP antibody. Nihon Rinsho Meneki Gakkai Kaishi. 2008;31(5):405-14.
14. Hasan T, Pertovaara M, Yli-Kerttula U, Luukkaala T, Korpela M. Seasonal variation of disease activity of systemic lupus erythematosus in Finland: A 1 year follow up study. Ann Rheum Dis. 2004;63(11):1498-500. (Pubitemid 39433958)
15. Amit M, Molad Y, Kiss S, Wysenbeek AJ. Seasonal variations in manifestations and activity of systemic lupus erythematosus. Br J Rheumatol. 1997;36(4):449-52.
16. Haga HJ, Brun JG, Rekvig OP, Wetterberg L. Seasonal variations in activity of systemic lupus erythematosus in a subarctic region. Lupus. 1999;8(4):269-73. (Pubitemid 29292090)
17. Sarkar K, Weinberg CR, Oddis CV, Medsger TA Jr, Plotz PH, Reveille JD, et al. Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups. Arthritis Rheum. 2005;52(8):2433-8. (Pubitemid 41117429)
18. Phillips BA, Zilko PJ, Garlepp MJ, Mastaglia FL. Seasonal occurrence of relapses in inflammatory myopathies: A preliminary study. J Neurol. 2002;249(4):441-4. (Pubitemid 34304619)